Literature DB >> 2857118

Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters.

B Meldrum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2857118     DOI： 10.1042/cs0680113

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN： 0143-5221            Impact factor:   6.124


× No keyword cloud information.
  61 in total

Review 1.  Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.

Authors:  V K Shukla; S Lemaire
Journal:  J Psychiatry Neurosci       Date:  1992-09       Impact factor: 6.186

2.  Acute hypoxia differentially affects the NMDA receptor NR1, NR2A and NR2B subunit mRNA levels in the developing chick optic tectum: stage-dependent plasticity in the 2B-2A ratio.

Authors:  Marina Vacotto; Melina Rapacioli; Vladimir Flores; Sara Fiszer de Plazas
Journal:  Neurochem Res       Date:  2010-07-02       Impact factor: 3.996

3.  Effects of NMDA receptor antagonists and sigma ligands on the acquisition of conditioned fear in mice.

Authors:  D J Sanger; D Joly
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Pharmacological characterization of the N-methyl-D-aspartate (NMDA) receptor-channel in rodent and dog brain and rat spinal cord using [3H]MK-801 binding.

Authors:  N A Sharif; J L Nunes; R L Whiting
Journal:  Neurochem Res       Date:  1991-05       Impact factor: 3.996

5.  Comparative analysis of seizures induced by intracerebroventricular administration of NMDA, kainate and quisqualate in mice.

Authors:  C Mathis; A Ungerer
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

6.  CGS-19755 and MK-801 selectively prevent rat striatal cholinergic and gabaergic neuronal degeneration induced by N-methyl-D-aspartate and ibotenate in vivo.

Authors:  D D Schoepp; C R Salhoff; C C Hillman; P L Ornstein
Journal:  J Neural Transm Gen Sect       Date:  1989

7.  Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats.

Authors:  K Wedzony; K Gołembiowska; M Zazula
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

8.  Developmental expression of N-methyl-D-aspartate (NMDA)-induced neurotoxicity, NMDA receptor function, and the NMDAR1 and glutamate-binding protein subunits in cerebellar granule cells in primary cultures.

Authors:  Y Xia; R E Ragan; E E Seah; M L Michaelis; E K Michaelis
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

9.  Behavioral studies on FR115427, a novel selective N-methyl-D-aspartate antagonist.

Authors:  H Nakanishi; K Katsuta; Y Ueda; H Takasugi; A Kuno; M Ohkubo; K Ogita; Y Yoneda; K Shirakawa; K Yoshida
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

10.  The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

Authors:  E H Wong; J A Kemp; T Priestley; A R Knight; G N Woodruff; L L Iversen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.